Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Neurovascular Embolization Coils Market Research Report 2026
Global Neurovascular Embolization Coils Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-08-23
Pages: 135 Pages
Report ld: 6469210
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
KEY FINDINGS
Intracranial aneurysm embolization remains the principal clinical demand for Neurovascular Embolization Coils
Product differentiation increasingly centers on complex geometry, softness, packing efficiency, and controllable detachment
Detachable coils dominate commercial neurovascular coiling, with mechanical and electrolytic detachment technologies coexisting
North America remains a leading high-value market, while Asia Pacific is gaining strategic importance
Competition combines established multinational neurovascular platforms with an expanding group of Chinese manufacturers
Neurovascular Embolization Coils Market Size(US$)
CAGR 2026-2032
5.6%
Market Size,2032
USD 1,553
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 1,120 million
Market Forecast in 2032(Value)
US$ 1,553 million
CAGR
5.6%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Neurovascular Embolization Coils market was valued at US$ 1058 million in 2025 and is anticipated to reach US$ 1553 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Neurovascular Embolization Coils are implantable neurointerventional devices delivered through a microcatheter into intracranial or other neurovascular lesions to mechanically fill the target space, promote local thrombus formation, and reduce or permanently occlude abnormal blood flow. The implant is generally constructed from radiopaque platinum or platinum-based alloys and engineered into complex three-dimensional, helical, or other secondary shapes, with different coil diameters, lengths, softness levels, and packing characteristics designed for framing, filling, and finishing during embolization. Mainstream systems use controllable mechanical or electrolytic detachment, while selected products incorporate hydrogel, polymer fibers, or other enhancement technologies to improve volumetric filling, conformability, or thrombogenic performance. The market primarily covers sterile single-use detachable neurovascular embolization coil systems used in endovascular treatment of intracranial aneurysms, with additional applications in cerebral arteriovenous malformations, arteriovenous fistulae, and other approved neurovascular abnormalities. Product differentiation is driven by coil geometry, softness, detachment reliability, packing efficiency, microcatheter compatibility, radiopacity, and the ability to provide predictable deployment in anatomically complex lesions.
MARKET TRENDS
Neurovascular Embolization Coils are evolving from relatively standardized platinum implants toward highly differentiated coil platforms optimized for specific stages of aneurysm embolization. Manufacturers are expanding complex three-dimensional framing designs, ultra-soft filling and finishing coils, longer and higher-volume configurations, and low-profile products compatible with smaller microcatheters. Product development increasingly emphasizes predictable wall apposition, reduced catheter kickback, improved packing density, controlled deployment, and rapid, reliable detachment. Bare-metal platinum and platinum-alloy coils remain the foundation of the market, while hydrogel, polymer-fiber, and other enhanced coil technologies provide additional differentiation in selected clinical settings. Another important direction is portfolio integration: major neurovascular companies increasingly position coils together with microcatheters, coil-assist stents, balloons, access devices, and other aneurysm treatment technologies, strengthening procedural compatibility and hospital-level account penetration rather than competing solely on the individual coil.
MARKET SEGMENTATION
By Company
- Stryker Corporation
- Medtronic plc
- Johnson & Johnson
- Terumo Corporation
- Penumbra, Inc.
- Balt Group
- Kaneka Corporation
- Genesis MedTech Group
- MicroPort NeuroScientific Corporation
- Wallaby Medical Holding, Inc.
- Shanghai HeartCare Medical Technology Corporation Limited
- Peijia Medical Limited
- Zylox-Tonbridge Medical Technology Co., Ltd.
- Beijing Taijieweiye Technology Co., Ltd.
- Shunmei Medical Co., LTD
- Hunan Ruikangtong Technology Development Co., Ltd.
- Shandong Visee Medical Devices Co., Ltd.
- Conlife Medical Scientific (Shenzhen) Co., Ltd.
- Zhuhai NeuroSafe Medical Co., Ltd.
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Complex Coils
- Helical Coils
Segment by Application
- Intracranial Aneurysm Embolization
- Cerebral Arteriovenous Malformation Embolization
- Other Neurovascular Abnormality Embolization
Segment by Category
- Framing Coils
- Filling Coils
- Finishing Coils
- Universal Coils
Segment by Division
- Standard Coils
- Soft Coils
- Extra Soft and Super Soft Coils
MARKET DYNAMICS
Drivers
Demand is supported by the continuing clinical burden of intracranial aneurysms, broader availability of neurovascular imaging, increasing detection of previously undiagnosed aneurysms, and expansion of specialized neurointerventional treatment capacity. Endovascular coiling remains an established minimally invasive treatment pathway for many ruptured and unruptured aneurysms and retains particular clinical value where preservation of the parent artery and immediate intrasaccular occlusion are required. Increasing numbers of trained neurointerventional specialists, expansion of comprehensive stroke centers, wider adoption of advanced microcatheter systems, and growing access to neurointervention in emerging healthcare markets are supporting procedure volumes. Continuous improvements in coil softness, shape stability, packing efficiency, and detachment reliability also expand physician choice and facilitate treatment of smaller, irregular, and technically challenging aneurysms.
Restraints
The market faces significant pricing and reimbursement pressure because intracranial aneurysm embolization commonly requires multiple coils in a single procedure, making implant expenditure highly visible to hospitals and payers. Centralized procurement, tendering, reimbursement controls, and hospital cost-management programs can therefore reduce average selling prices even when procedural volumes rise. Treatment remains highly operator dependent and requires sophisticated imaging, experienced neurointerventional teams, and specialized procedural infrastructure, limiting adoption in healthcare systems with insufficient neurovascular capacity. In addition, flow-diverting stents and intrasaccular flow-disruption devices have expanded the treatment options available for selected aneurysm anatomies, particularly complex and wide-neck lesions, creating substitution pressure on conventional coil-only procedures in some clinical segments.
Opportunities
The strongest structural opportunities lie in broader neurointerventional penetration in Asia Pacific and other underserved markets, continued localization of manufacturing, and expansion of differentiated coil portfolios across multiple price and performance tiers. Products that combine low radial force with stable framing, higher volumetric filling, smaller delivery profiles, and predictable detachment can address unmet needs in small, irregular, distal, and difficult-to-pack aneurysms. Hydrogel-enhanced, fiber-enhanced, and other advanced coil technologies also provide opportunities to improve packing characteristics and support premium positioning where clinical evidence justifies differentiated performance. For Chinese manufacturers, expansion from domestic commercialization into regulated overseas markets represents an additional growth pathway, while multinational companies can benefit from broader hospital access, integrated aneurysm treatment portfolios, and region-specific product configurations.
Challenges
Neurovascular Embolization Coils require extremely consistent performance because deployment takes place within fragile intracranial vessels and aneurysm sacs where device deformation, premature detachment, migration, excessive radial force, or delivery resistance can result in serious clinical consequences. Manufacturers therefore face stringent requirements for raw-material consistency, microcoil forming, joint integrity, detachment reliability, fatigue performance, sterility, packaging, traceability, and post-market surveillance. Commercial success also depends on obtaining regulatory approvals across multiple jurisdictions while maintaining extensive physician training and clinical support. At the same time, intensifying competition among global platforms and emerging domestic manufacturers is increasing pressure on pricing and product refresh cycles, while the growing use of alternative aneurysm technologies requires coil manufacturers to demonstrate continued clinical relevance rather than relying solely on established procedure volumes.
INDUSTRY CHAIN ANALYSIS
The upstream supply chain for Neurovascular Embolization Coils is concentrated in high-specification medical-grade materials and precision components. Key inputs include platinum and platinum-based alloy wire, tungsten-containing radiopaque alloys, stainless steel or other delivery-wire materials, polymer fibers, hydrogel or specialty polymer materials, micro-scale joining and detachment components, medical-grade packaging, and sterilization services. Material purity, wire dimensional control, mechanical properties, radiopacity, biocompatibility, and lot-to-lot consistency directly influence implant performance. Manufacturing requires precision wire processing, primary and secondary coil forming, shape setting, micro-welding or joining, detachment-interface assembly, surface treatment, cleanroom assembly, inspection, packaging, sterilization, and extensive mechanical and functional validation. These processes create meaningful technical barriers despite the relatively small physical size of the final implant.
The midstream value pool is concentrated in proprietary coil design, manufacturing know-how, detachment technology, quality systems, regulatory registrations, clinical evidence, and physician-facing commercial capabilities. Downstream demand is generated primarily by tertiary hospitals, comprehensive stroke centers, academic medical centers, and other hospitals with established neurointerventional capabilities. A significant share of value is therefore created outside raw materials themselves: intellectual property, validated manufacturing processes, regulatory compliance, clinical education, procedural support, and hospital access account for a substantial portion of the economic value of the final product. Direct sales are important in large developed markets and major hospital accounts, while distributors remain significant in smaller and geographically fragmented markets.
SEGMENT INSIGHTS
By coil shape, complex three-dimensional coils represent the central commercial category because their spatial configurations are designed to establish a stable framework, improve aneurysm-wall apposition, and support subsequent filling, while helical coils remain an important complementary option for versatile filling and finishing. By embolization role, product portfolios are increasingly structured around framing, filling, and finishing functions, although certain coil families are designed for use across multiple stages. Softness has also become a major competitive variable, with standard or structurally supportive coils used where framing stability is required and progressively softer coils used to occupy residual spaces while reducing force against the aneurysm wall.
By technology, bare-metal platinum and platinum-alloy detachable coils continue to form the core market, while polymer- or hydrogel-enhanced products represent a differentiated segment focused on higher volumetric filling or modified thrombogenic characteristics. Mechanical and electrolytic detachment technologies both maintain established commercial positions, making reliability, deployment speed, repositionability, and compatibility with existing hospital workflows important purchasing considerations. Size architecture is another major source of differentiation: broad portfolios spanning small-diameter finishing coils through longer and higher-volume framing or filling coils allow suppliers to cover a greater proportion of procedural requirements and strengthen their position within hospital accounts.
DOWNSTREAM MARKET OPPORTUNITIES
Intracranial aneurysm treatment accounts for the dominant downstream opportunity, covering both ruptured and unruptured aneurysms treated through endovascular coil embolization. The opportunity is increasingly differentiated by aneurysm anatomy rather than simply by procedure count. Small and irregular aneurysms create demand for ultra-soft, low-profile coils; larger aneurysms require efficient volumetric filling; and wide-neck or complex aneurysms frequently require coils to operate as part of a broader treatment strategy involving adjunctive stents or balloons. Cerebral arteriovenous malformations, arteriovenous fistulae, and other approved neurovascular embolization indications provide additional demand. Expansion of neurointerventional services into secondary regional centers and emerging healthcare systems creates further opportunity as diagnosis, referral pathways, and physician training improve.
REGIONAL INSIGHTS
Fastest-Growing Region: Asia Pacific
North America remains one of the most important high-value markets for Neurovascular Embolization Coils, supported by a mature neurointerventional infrastructure, broad access to advanced aneurysm treatment technologies, established reimbursement pathways, and extensive participation by leading multinational manufacturers. Europe also represents a mature market with sophisticated clinical practice, although procurement structures and country-level reimbursement conditions create greater pricing heterogeneity. Both regions increasingly use coils as part of multi-technology aneurysm treatment portfolios, with clinical selection influenced by lesion anatomy, physician preference, and availability of adjunctive or alternative devices.
- XX.X%CAGR*
- XXXXUS$ Million
- XXXXREGIONAL SHARE
BY TYPE,2021-2032(US $ MILLION)
Complex Coils
Helical Coils
BY APPLICATION，2021-2032(US $ MILLION）
Intracranial Aneurysm Embolization
Cerebral Arteriovenous Malformation Embolization
Other Neurovascular Abnormality Embolization
Asia Pacific is becoming increasingly important to the competitive structure of the market. Japan maintains an established neurointerventional market and domestic manufacturing base, while China combines rapid development of neurointerventional centers with growing penetration of locally manufactured coil systems. In China, centralized procurement and hospital cost control place pressure on unit pricing, but expanding product availability, increased procedural accessibility, and accelerated domestic substitution support unit demand. Chinese manufacturers are also extending regulatory registrations beyond their domestic market, increasing competitive interaction with multinational suppliers in selected emerging and developed markets. Other Asian markets remain more dependent on imported products and distributor networks, creating opportunities for suppliers with broad regulatory coverage and efficient regional channels.
REPORT SCOPE
This report delivers a comprehensive overview of the global Neurovascular Embolization Coils market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neurovascular Embolization Coils. The Neurovascular Embolization Coils market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Neurovascular Embolization Coils market comprehensively. Regional market sizes by Type, by Application, by Embolization Role, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Neurovascular Embolization Coils manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Embolization Role, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Neurovascular Embolization Coils manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Neurovascular Embolization Coils sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Neurovascular Embolization Coils Market Overview
1.1 Product Definition
1.2 Neurovascular Embolization Coils by Type
1.2.1 Global Neurovascular Embolization Coils Market Value by Type: 2025 vs 2032
1.2.2 Complex Coils
1.2.3 Helical Coils
1.3 Neurovascular Embolization Coils by Embolization Role
1.3.1 Global Neurovascular Embolization Coils Market Value by Embolization Role: 2025 vs 2032
1.3.2 Framing Coils
1.3.3 Filling Coils
1.3.4 Finishing Coils
1.3.5 Universal Coils
1.4 Neurovascular Embolization Coils by Coil Softness
1.4.1 Global Neurovascular Embolization Coils Market Value by Coil Softness: 2025 vs 2032
1.4.2 Standard Coils
1.4.3 Soft Coils
1.4.4 Extra Soft and Super Soft Coils
1.5 Neurovascular Embolization Coils by Detachment Mechanism
1.5.1 Global Neurovascular Embolization Coils Market Value by Detachment Mechanism: 2025 vs 2032
1.5.2 Mechanical Detachment Coils
1.5.3 Electrolytic Detachment Coils
1.5.4 Others
1.6 Neurovascular Embolization Coils by Application
1.6.1 Global Neurovascular Embolization Coils Market Value by Application: 2025 vs 2032
1.6.2 Intracranial Aneurysm Embolization
1.6.3 Cerebral Arteriovenous Malformation Embolization
1.6.4 Other Neurovascular Abnormality Embolization
1.7 Global Neurovascular Embolization Coils Market Size Estimates and Forecasts
1.7.1 Global Neurovascular Embolization Coils Revenue 2021–2032
1.7.2 Global Neurovascular Embolization Coils Sales 2021–2032
1.7.3 Global Neurovascular Embolization Coils Market Average Price (2021–2032)
1.8 Assumptions and Limitations
2 Neurovascular Embolization Coils Market Competition by Manufacturers
2.1 Global Neurovascular Embolization Coils Sales Market Share by Manufacturers (2021–2026)
2.2 Global Neurovascular Embolization Coils Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Neurovascular Embolization Coils Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Neurovascular Embolization Coils, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Neurovascular Embolization Coils, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Neurovascular Embolization Coils, Product Types and Applications
2.7 Global Key Manufacturers of Neurovascular Embolization Coils, Date of Entry into the Industry
2.8 Global Neurovascular Embolization Coils Market Competitive Situation and Trends
2.8.1 Global Neurovascular Embolization Coils Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Neurovascular Embolization Coils Players Market Share by Revenue
2.8.3 Global Neurovascular Embolization Coils Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neurovascular Embolization Coils Market Scenario by Region
3.1 Global Neurovascular Embolization Coils Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Neurovascular Embolization Coils Sales by Region: 2021–2032
3.2.1 Global Neurovascular Embolization Coils Sales by Region: 2021–2026
3.2.2 Global Neurovascular Embolization Coils Sales by Region: 2027–2032
3.3 Global Neurovascular Embolization Coils Revenue by Region: 2021–2032
3.3.1 Global Neurovascular Embolization Coils Revenue by Region: 2021–2026
3.3.2 Global Neurovascular Embolization Coils Revenue by Region: 2027–2032
3.4 North America Neurovascular Embolization Coils Market Facts & Figures by Country
3.4.1 North America Neurovascular Embolization Coils Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Neurovascular Embolization Coils Sales by Country (2021–2032)
3.4.3 North America Neurovascular Embolization Coils Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neurovascular Embolization Coils Market Facts & Figures by Country
3.5.1 Europe Neurovascular Embolization Coils Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Neurovascular Embolization Coils Sales by Country (2021–2032)
3.5.3 Europe Neurovascular Embolization Coils Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurovascular Embolization Coils Market Facts & Figures by Region
3.6.1 Asia Pacific Neurovascular Embolization Coils Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Neurovascular Embolization Coils Sales by Region (2021–2032)
3.6.3 Asia Pacific Neurovascular Embolization Coils Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neurovascular Embolization Coils Market Facts & Figures by Country
3.7.1 Latin America Neurovascular Embolization Coils Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Neurovascular Embolization Coils Sales by Country (2021–2032)
3.7.3 Latin America Neurovascular Embolization Coils Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurovascular Embolization Coils Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurovascular Embolization Coils Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Neurovascular Embolization Coils Sales by Country (2021–2032)
3.8.3 Middle East and Africa Neurovascular Embolization Coils Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Neurovascular Embolization Coils Sales by Type (2021–2032)
4.1.1 Global Neurovascular Embolization Coils Sales by Type (2021–2026)
4.1.2 Global Neurovascular Embolization Coils Sales by Type (2027–2032)
4.1.3 Global Neurovascular Embolization Coils Sales Market Share by Type (2021–2032)
4.2 Global Neurovascular Embolization Coils Revenue by Type (2021–2032)
4.2.1 Global Neurovascular Embolization Coils Revenue by Type (2021–2026)
4.2.2 Global Neurovascular Embolization Coils Revenue by Type (2027–2032)
4.2.3 Global Neurovascular Embolization Coils Revenue Market Share by Type (2021–2032)
4.3 Global Neurovascular Embolization Coils Price by Type (2021–2032)
5 Segment by Application
5.1 Global Neurovascular Embolization Coils Sales by Application (2021–2032)
5.1.1 Global Neurovascular Embolization Coils Sales by Application (2021–2026)
5.1.2 Global Neurovascular Embolization Coils Sales by Application (2027–2032)
5.1.3 Global Neurovascular Embolization Coils Sales Market Share by Application (2021–2032)
5.2 Global Neurovascular Embolization Coils Revenue by Application (2021–2032)
5.2.1 Global Neurovascular Embolization Coils Revenue by Application (2021–2026)
5.2.2 Global Neurovascular Embolization Coils Revenue by Application (2027–2032)
5.2.3 Global Neurovascular Embolization Coils Revenue Market Share by Application (2021–2032)
5.3 Global Neurovascular Embolization Coils Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Stryker Corporation
6.1.1 Stryker Corporation Company Information
6.1.2 Stryker Corporation Description and Business Overview
6.1.3 Stryker Corporation Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Stryker Corporation Neurovascular Embolization Coils Product Portfolio
6.1.5 Stryker Corporation Recent Developments/Updates
6.2 Medtronic plc
6.2.1 Medtronic plc Company Information
6.2.2 Medtronic plc Description and Business Overview
6.2.3 Medtronic plc Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Medtronic plc Neurovascular Embolization Coils Product Portfolio
6.2.5 Medtronic plc Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Johnson & Johnson Neurovascular Embolization Coils Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Terumo Corporation
6.4.1 Terumo Corporation Company Information
6.4.2 Terumo Corporation Description and Business Overview
6.4.3 Terumo Corporation Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Terumo Corporation Neurovascular Embolization Coils Product Portfolio
6.4.5 Terumo Corporation Recent Developments/Updates
6.5 Penumbra, Inc.
6.5.1 Penumbra, Inc. Company Information
6.5.2 Penumbra, Inc. Description and Business Overview
6.5.3 Penumbra, Inc. Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Penumbra, Inc. Neurovascular Embolization Coils Product Portfolio
6.5.5 Penumbra, Inc. Recent Developments/Updates
6.6 Balt Group
6.6.1 Balt Group Company Information
6.6.2 Balt Group Description and Business Overview
6.6.3 Balt Group Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Balt Group Neurovascular Embolization Coils Product Portfolio
6.6.5 Balt Group Recent Developments/Updates
6.7 Kaneka Corporation
6.7.1 Kaneka Corporation Company Information
6.7.2 Kaneka Corporation Description and Business Overview
6.7.3 Kaneka Corporation Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Kaneka Corporation Neurovascular Embolization Coils Product Portfolio
6.7.5 Kaneka Corporation Recent Developments/Updates
6.8 Genesis MedTech Group
6.8.1 Genesis MedTech Group Company Information
6.8.2 Genesis MedTech Group Description and Business Overview
6.8.3 Genesis MedTech Group Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Genesis MedTech Group Neurovascular Embolization Coils Product Portfolio
6.8.5 Genesis MedTech Group Recent Developments/Updates
6.9 MicroPort NeuroScientific Corporation
6.9.1 MicroPort NeuroScientific Corporation Company Information
6.9.2 MicroPort NeuroScientific Corporation Description and Business Overview
6.9.3 MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Product Portfolio
6.9.5 MicroPort NeuroScientific Corporation Recent Developments/Updates
6.10 Wallaby Medical Holding, Inc.
6.10.1 Wallaby Medical Holding, Inc. Company Information
6.10.2 Wallaby Medical Holding, Inc. Description and Business Overview
6.10.3 Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Product Portfolio
6.10.5 Wallaby Medical Holding, Inc. Recent Developments/Updates
6.11 Shanghai HeartCare Medical Technology Corporation Limited
6.11.1 Shanghai HeartCare Medical Technology Corporation Limited Company Information
6.11.2 Shanghai HeartCare Medical Technology Corporation Limited Description and Business Overview
6.11.3 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Product Portfolio
6.11.5 Shanghai HeartCare Medical Technology Corporation Limited Recent Developments/Updates
6.12 Peijia Medical Limited
6.12.1 Peijia Medical Limited Company Information
6.12.2 Peijia Medical Limited Description and Business Overview
6.12.3 Peijia Medical Limited Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Peijia Medical Limited Neurovascular Embolization Coils Product Portfolio
6.12.5 Peijia Medical Limited Recent Developments/Updates
6.13 Zylox-Tonbridge Medical Technology Co., Ltd.
6.13.1 Zylox-Tonbridge Medical Technology Co., Ltd. Company Information
6.13.2 Zylox-Tonbridge Medical Technology Co., Ltd. Description and Business Overview
6.13.3 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Product Portfolio
6.13.5 Zylox-Tonbridge Medical Technology Co., Ltd. Recent Developments/Updates
6.14 Beijing Taijieweiye Technology Co., Ltd.
6.14.1 Beijing Taijieweiye Technology Co., Ltd. Company Information
6.14.2 Beijing Taijieweiye Technology Co., Ltd. Description and Business Overview
6.14.3 Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Product Portfolio
6.14.5 Beijing Taijieweiye Technology Co., Ltd. Recent Developments/Updates
6.15 Shunmei Medical Co., LTD
6.15.1 Shunmei Medical Co., LTD Company Information
6.15.2 Shunmei Medical Co., LTD Description and Business Overview
6.15.3 Shunmei Medical Co., LTD Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Shunmei Medical Co., LTD Neurovascular Embolization Coils Product Portfolio
6.15.5 Shunmei Medical Co., LTD Recent Developments/Updates
6.16 Hunan Ruikangtong Technology Development Co., Ltd.
6.16.1 Hunan Ruikangtong Technology Development Co., Ltd. Company Information
6.16.2 Hunan Ruikangtong Technology Development Co., Ltd. Description and Business Overview
6.16.3 Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Product Portfolio
6.16.5 Hunan Ruikangtong Technology Development Co., Ltd. Recent Developments/Updates
6.17 Shandong Visee Medical Devices Co., Ltd.
6.17.1 Shandong Visee Medical Devices Co., Ltd. Company Information
6.17.2 Shandong Visee Medical Devices Co., Ltd. Description and Business Overview
6.17.3 Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Product Portfolio
6.17.5 Shandong Visee Medical Devices Co., Ltd. Recent Developments/Updates
6.18 Conlife Medical Scientific (Shenzhen) Co., Ltd.
6.18.1 Conlife Medical Scientific (Shenzhen) Co., Ltd. Company Information
6.18.2 Conlife Medical Scientific (Shenzhen) Co., Ltd. Description and Business Overview
6.18.3 Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Product Portfolio
6.18.5 Conlife Medical Scientific (Shenzhen) Co., Ltd. Recent Developments/Updates
6.19 Zhuhai NeuroSafe Medical Co., Ltd.
6.19.1 Zhuhai NeuroSafe Medical Co., Ltd. Company Information
6.19.2 Zhuhai NeuroSafe Medical Co., Ltd. Description and Business Overview
6.19.3 Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Product Portfolio
6.19.5 Zhuhai NeuroSafe Medical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurovascular Embolization Coils Industry Chain Analysis
7.2 Neurovascular Embolization Coils Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurovascular Embolization Coils Production Mode & Process Analysis
7.4 Neurovascular Embolization Coils Sales and Marketing
7.4.1 Neurovascular Embolization Coils Sales Channels
7.4.2 Neurovascular Embolization Coils Distributors
7.5 Neurovascular Embolization Coils Customer Analysis
8 Neurovascular Embolization Coils Market Dynamics
8.1 Neurovascular Embolization Coils Industry Trends
8.2 Neurovascular Embolization Coils Market Drivers
8.3 Neurovascular Embolization Coils Market Challenges
8.4 Neurovascular Embolization Coils Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Neurovascular Embolization Coils Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Neurovascular Embolization Coils Market Value by Embolization Role (US$ Million), 2025 vs 2032
Table 3. Global Neurovascular Embolization Coils Market Value by Coil Softness (US$ Million), 2025 vs 2032
Table 4. Global Neurovascular Embolization Coils Market Value by Detachment Mechanism (US$ Million), 2025 vs 2032
Table 5. Global Neurovascular Embolization Coils Market Value by Application (US$ Million), 2025 vs 2032
Table 6. Global Neurovascular Embolization Coils Market Competitive Situation by Manufacturers in 2025
Table 7. Global Neurovascular Embolization Coils Sales (K Units) of Key Manufacturers (2021–2026)
Table 8. Global Neurovascular Embolization Coils Sales Market Share by Manufacturers (2021–2026)
Table 9. Global Neurovascular Embolization Coils Revenue (US$ Million) by Manufacturers (2021–2026)
Table 10. Global Neurovascular Embolization Coils Revenue Share by Manufacturers (2021–2026)
Table 11. Global Market Neurovascular Embolization Coils Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 12. Global Key Players of Neurovascular Embolization Coils, Industry Ranking, 2023 vs 2024 vs 2025
Table 13. Global Key Manufacturers of Neurovascular Embolization Coils, Manufacturing Sites and Headquarters
Table 14. Global Key Manufacturers of Neurovascular Embolization Coils, Product Types and Applications
Table 15. Global Key Manufacturers of Neurovascular Embolization Coils, Date of Entry into the Industry
Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Neurovascular Embolization Coils Companies by Tier (Tier 1, Tier 2, Tier 3), based on Neurovascular Embolization Coils Revenue, 2025
Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 19. Global Neurovascular Embolization Coils Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 20. Global Neurovascular Embolization Coils Sales by Region (K Units), 2021–2026
Table 21. Global Neurovascular Embolization Coils Sales Market Share by Region (2021–2026)
Table 22. Global Neurovascular Embolization Coils Sales by Region (K Units), 2027–2032
Table 23. Global Neurovascular Embolization Coils Sales Market Share by Region (2027–2032)
Table 24. Global Neurovascular Embolization Coils Revenue by Region (US$ Million), 2021–2026
Table 25. Global Neurovascular Embolization Coils Revenue Market Share by Region (2021–2026)
Table 26. Global Neurovascular Embolization Coils Revenue by Region (US$ Million), 2027–2032
Table 27. Global Neurovascular Embolization Coils Revenue Market Share by Region (2027–2032)
Table 28. North America Neurovascular Embolization Coils Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. North America Neurovascular Embolization Coils Sales by Country (K Units), 2021–2026
Table 30. North America Neurovascular Embolization Coils Sales by Country (K Units), 2027–2032
Table 31. North America Neurovascular Embolization Coils Revenue by Country (US$ Million), 2021–2026
Table 32. North America Neurovascular Embolization Coils Revenue by Country (US$ Million), 2027–2032
Table 33. Europe Neurovascular Embolization Coils Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Europe Neurovascular Embolization Coils Sales by Country (K Units), 2021–2026
Table 35. Europe Neurovascular Embolization Coils Sales by Country (K Units), 2027–2032
Table 36. Europe Neurovascular Embolization Coils Revenue by Country (US$ Million), 2021–2026
Table 37. Europe Neurovascular Embolization Coils Revenue by Country (US$ Million), 2027–2032
Table 38. Asia Pacific Neurovascular Embolization Coils Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 39. Asia Pacific Neurovascular Embolization Coils Sales by Region (K Units), 2021–2026
Table 40. Asia Pacific Neurovascular Embolization Coils Sales by Region (K Units), 2027–2032
Table 41. Asia Pacific Neurovascular Embolization Coils Revenue by Region (US$ Million), 2021–2026
Table 42. Asia Pacific Neurovascular Embolization Coils Revenue by Region (US$ Million), 2027–2032
Table 43. Latin America Neurovascular Embolization Coils Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Latin America Neurovascular Embolization Coils Sales by Country (K Units), 2021–2026
Table 45. Latin America Neurovascular Embolization Coils Sales by Country (K Units), 2027–2032
Table 46. Latin America Neurovascular Embolization Coils Revenue by Country (US$ Million), 2021–2026
Table 47. Latin America Neurovascular Embolization Coils Revenue by Country (US$ Million), 2027–2032
Table 48. Middle East and Africa Neurovascular Embolization Coils Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Middle East and Africa Neurovascular Embolization Coils Sales by Country (K Units), 2021–2026
Table 50. Middle East and Africa Neurovascular Embolization Coils Sales by Country (K Units), 2027–2032
Table 51. Middle East and Africa Neurovascular Embolization Coils Revenue by Country (US$ Million), 2021–2026
Table 52. Middle East and Africa Neurovascular Embolization Coils Revenue by Country (US$ Million), 2027–2032
Table 53. Global Neurovascular Embolization Coils Sales (K Units) by Type (2021–2026)
Table 54. Global Neurovascular Embolization Coils Sales (K Units) by Type (2027–2032)
Table 55. Global Neurovascular Embolization Coils Sales Market Share by Type (2021–2026)
Table 56. Global Neurovascular Embolization Coils Sales Market Share by Type (2027–2032)
Table 57. Global Neurovascular Embolization Coils Revenue (US$ Million) by Type (2021–2026)
Table 58. Global Neurovascular Embolization Coils Revenue (US$ Million) by Type (2027–2032)
Table 59. Global Neurovascular Embolization Coils Revenue Market Share by Type (2021–2026)
Table 60. Global Neurovascular Embolization Coils Revenue Market Share by Type (2027–2032)
Table 61. Global Neurovascular Embolization Coils Price (US$/Unit) by Type (2021–2026)
Table 62. Global Neurovascular Embolization Coils Price (US$/Unit) by Type (2027–2032)
Table 63. Global Neurovascular Embolization Coils Sales (K Units) by Application (2021–2026)
Table 64. Global Neurovascular Embolization Coils Sales (K Units) by Application (2027–2032)
Table 65. Global Neurovascular Embolization Coils Sales Market Share by Application (2021–2026)
Table 66. Global Neurovascular Embolization Coils Sales Market Share by Application (2027–2032)
Table 67. Global Neurovascular Embolization Coils Revenue (US$ Million) by Application (2021–2026)
Table 68. Global Neurovascular Embolization Coils Revenue (US$ Million) by Application (2027–2032)
Table 69. Global Neurovascular Embolization Coils Revenue Market Share by Application (2021–2026)
Table 70. Global Neurovascular Embolization Coils Revenue Market Share by Application (2027–2032)
Table 71. Global Neurovascular Embolization Coils Price (US$/Unit) by Application (2021–2026)
Table 72. Global Neurovascular Embolization Coils Price (US$/Unit) by Application (2027–2032)
Table 73. Stryker Corporation Company Information
Table 74. Stryker Corporation Description and Business Overview
Table 75. Stryker Corporation Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 76. Stryker Corporation Neurovascular Embolization Coils Product
Table 77. Stryker Corporation Recent Developments/Updates
Table 78. Medtronic plc Company Information
Table 79. Medtronic plc Description and Business Overview
Table 80. Medtronic plc Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 81. Medtronic plc Neurovascular Embolization Coils Product
Table 82. Medtronic plc Recent Developments/Updates
Table 83. Johnson & Johnson Company Information
Table 84. Johnson & Johnson Description and Business Overview
Table 85. Johnson & Johnson Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 86. Johnson & Johnson Neurovascular Embolization Coils Product
Table 87. Johnson & Johnson Recent Developments/Updates
Table 88. Terumo Corporation Company Information
Table 89. Terumo Corporation Description and Business Overview
Table 90. Terumo Corporation Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 91. Terumo Corporation Neurovascular Embolization Coils Product
Table 92. Terumo Corporation Recent Developments/Updates
Table 93. Penumbra, Inc. Company Information
Table 94. Penumbra, Inc. Description and Business Overview
Table 95. Penumbra, Inc. Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 96. Penumbra, Inc. Neurovascular Embolization Coils Product
Table 97. Penumbra, Inc. Recent Developments/Updates
Table 98. Balt Group Company Information
Table 99. Balt Group Description and Business Overview
Table 100. Balt Group Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 101. Balt Group Neurovascular Embolization Coils Product
Table 102. Balt Group Recent Developments/Updates
Table 103. Kaneka Corporation Company Information
Table 104. Kaneka Corporation Description and Business Overview
Table 105. Kaneka Corporation Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 106. Kaneka Corporation Neurovascular Embolization Coils Product
Table 107. Kaneka Corporation Recent Developments/Updates
Table 108. Genesis MedTech Group Company Information
Table 109. Genesis MedTech Group Description and Business Overview
Table 110. Genesis MedTech Group Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 111. Genesis MedTech Group Neurovascular Embolization Coils Product
Table 112. Genesis MedTech Group Recent Developments/Updates
Table 113. MicroPort NeuroScientific Corporation Company Information
Table 114. MicroPort NeuroScientific Corporation Description and Business Overview
Table 115. MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 116. MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Product
Table 117. MicroPort NeuroScientific Corporation Recent Developments/Updates
Table 118. Wallaby Medical Holding, Inc. Company Information
Table 119. Wallaby Medical Holding, Inc. Description and Business Overview
Table 120. Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 121. Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Product
Table 122. Wallaby Medical Holding, Inc. Recent Developments/Updates
Table 123. Shanghai HeartCare Medical Technology Corporation Limited Company Information
Table 124. Shanghai HeartCare Medical Technology Corporation Limited Description and Business Overview
Table 125. Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 126. Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Product
Table 127. Shanghai HeartCare Medical Technology Corporation Limited Recent Developments/Updates
Table 128. Peijia Medical Limited Company Information
Table 129. Peijia Medical Limited Description and Business Overview
Table 130. Peijia Medical Limited Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 131. Peijia Medical Limited Neurovascular Embolization Coils Product
Table 132. Peijia Medical Limited Recent Developments/Updates
Table 133. Zylox-Tonbridge Medical Technology Co., Ltd. Company Information
Table 134. Zylox-Tonbridge Medical Technology Co., Ltd. Description and Business Overview
Table 135. Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 136. Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Product
Table 137. Zylox-Tonbridge Medical Technology Co., Ltd. Recent Developments/Updates
Table 138. Beijing Taijieweiye Technology Co., Ltd. Company Information
Table 139. Beijing Taijieweiye Technology Co., Ltd. Description and Business Overview
Table 140. Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 141. Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Product
Table 142. Beijing Taijieweiye Technology Co., Ltd. Recent Developments/Updates
Table 143. Shunmei Medical Co., LTD Company Information
Table 144. Shunmei Medical Co., LTD Description and Business Overview
Table 145. Shunmei Medical Co., LTD Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 146. Shunmei Medical Co., LTD Neurovascular Embolization Coils Product
Table 147. Shunmei Medical Co., LTD Recent Developments/Updates
Table 148. Hunan Ruikangtong Technology Development Co., Ltd. Company Information
Table 149. Hunan Ruikangtong Technology Development Co., Ltd. Description and Business Overview
Table 150. Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 151. Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Product
Table 152. Hunan Ruikangtong Technology Development Co., Ltd. Recent Developments/Updates
Table 153. Shandong Visee Medical Devices Co., Ltd. Company Information
Table 154. Shandong Visee Medical Devices Co., Ltd. Description and Business Overview
Table 155. Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 156. Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Product
Table 157. Shandong Visee Medical Devices Co., Ltd. Recent Developments/Updates
Table 158. Conlife Medical Scientific (Shenzhen) Co., Ltd. Company Information
Table 159. Conlife Medical Scientific (Shenzhen) Co., Ltd. Description and Business Overview
Table 160. Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 161. Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Product
Table 162. Conlife Medical Scientific (Shenzhen) Co., Ltd. Recent Developments/Updates
Table 163. Zhuhai NeuroSafe Medical Co., Ltd. Company Information
Table 164. Zhuhai NeuroSafe Medical Co., Ltd. Description and Business Overview
Table 165. Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 166. Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Product
Table 167. Zhuhai NeuroSafe Medical Co., Ltd. Recent Developments/Updates
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Neurovascular Embolization Coils Distributors List
Table 171. Neurovascular Embolization Coils Customers List
Table 172. Neurovascular Embolization Coils Market Trends
Table 173. Neurovascular Embolization Coils Market Drivers
Table 174. Neurovascular Embolization Coils Market Challenges
Table 175. Neurovascular Embolization Coils Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
Table 179. Authors List of This Report
List of Figures
Figure 1. Product Picture of Neurovascular Embolization Coils
Figure 2. Global Neurovascular Embolization Coils Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Neurovascular Embolization Coils Market Share by Type: 2025 & 2032
Figure 4. Complex Coils Product Picture
Figure 5. Helical Coils Product Picture
Figure 6. Global Neurovascular Embolization Coils Market Value by Embolization Role (US$ Million), 2021–2032
Figure 7. Global Neurovascular Embolization Coils Market Share by Embolization Role: 2025 vs 2032
Figure 8. Framing Coils Product Picture
Figure 9. Filling Coils Product Picture
Figure 10. Finishing Coils Product Picture
Figure 11. Universal Coils Product Picture
Figure 12. Global Neurovascular Embolization Coils Market Value by Coil Softness (US$ Million), 2021–2032
Figure 13. Global Neurovascular Embolization Coils Market Share by Coil Softness: 2025 vs 2032
Figure 14. Standard Coils Product Picture
Figure 15. Soft Coils Product Picture
Figure 16. Extra Soft and Super Soft Coils Product Picture
Figure 17. Global Neurovascular Embolization Coils Market Value by Detachment Mechanism (US$ Million), 2021–2032
Figure 18. Global Neurovascular Embolization Coils Market Share by Detachment Mechanism: 2025 vs 2032
Figure 19. Mechanical Detachment Coils Product Picture
Figure 20. Electrolytic Detachment Coils Product Picture
Figure 21. Others Product Picture
Figure 22. Global Neurovascular Embolization Coils Market Value by Application (US$ Million), 2021–2032
Figure 23. Global Neurovascular Embolization Coils Market Share by Application: 2025 & 2032
Figure 24. Intracranial Aneurysm Embolization
Figure 25. Cerebral Arteriovenous Malformation Embolization
Figure 26. Other Neurovascular Abnormality Embolization
Figure 27. Global Neurovascular Embolization Coils Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 28. Global Neurovascular Embolization Coils Market Size (US$ Million), 2021–2032
Figure 29. Global Neurovascular Embolization Coils Sales (K Units), 2021–2032
Figure 30. Global Neurovascular Embolization Coils Average Price (US$/Unit), 2021–2032
Figure 31. Neurovascular Embolization Coils Report Years Considered
Figure 32. Neurovascular Embolization Coils Sales Share by Manufacturers in 2025
Figure 33. Global Neurovascular Embolization Coils Revenue Share by Manufacturers in 2025
Figure 34. Top 5 and Top 10 Global Neurovascular Embolization Coils Players: Market Share by Revenue in Neurovascular Embolization Coils in 2025
Figure 35. Neurovascular Embolization Coils Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 36. Global Neurovascular Embolization Coils Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 37. North America Neurovascular Embolization Coils Sales Market Share by Country (2021–2032)
Figure 38. North America Neurovascular Embolization Coils Revenue Market Share by Country (2021–2032)
Figure 39. U.S. Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Canada Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Europe Neurovascular Embolization Coils Sales Market Share by Country (2021–2032)
Figure 42. Europe Neurovascular Embolization Coils Revenue Market Share by Country (2021–2032)
Figure 43. Germany Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. France Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. U.K. Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Italy Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Russia Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Asia Pacific Neurovascular Embolization Coils Sales Market Share by Region (2021–2032)
Figure 49. Asia Pacific Neurovascular Embolization Coils Revenue Market Share by Region (2021–2032)
Figure 50. China Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Japan Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. South Korea Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. India Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Australia Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Taiwan Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Indonesia Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Thailand Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Malaysia Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Philippines Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Latin America Neurovascular Embolization Coils Sales Market Share by Country (2021–2032)
Figure 61. Latin America Neurovascular Embolization Coils Revenue Market Share by Country (2021–2032)
Figure 62. Mexico Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Brazil Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. Argentina Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 65. Middle East and Africa Neurovascular Embolization Coils Sales Market Share by Country (2021–2032)
Figure 66. Middle East and Africa Neurovascular Embolization Coils Revenue Market Share by Country (2021–2032)
Figure 67. Turkey Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 68. Saudi Arabia Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 69. U.A.E Neurovascular Embolization Coils Revenue Growth Rate (US$ Million), 2021–2032
Figure 70. Global Sales Market Share of Neurovascular Embolization Coils by Type (2021–2032)
Figure 71. Global Revenue Market Share of Neurovascular Embolization Coils by Type (2021–2032)
Figure 72. Global Neurovascular Embolization Coils Price (US$/Unit) by Type (2021–2032)
Figure 73. Global Sales Market Share of Neurovascular Embolization Coils by Application (2021–2032)
Figure 74. Global Revenue Market Share of Neurovascular Embolization Coils by Application (2021–2032)
Figure 75. Global Neurovascular Embolization Coils Price (US$/Unit) by Application (2021–2032)
Figure 76. Neurovascular Embolization Coils Value Chain
Figure 77. Channels of Distribution (Direct Vs Distribution)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Neurovascular Embolization Coils market size from 2026 to 2032?
The annual compound growth rate of the global Neurovascular Embolization Coils market is 5.6% 2026 to 2032.
What was the global market size of Neurovascular Embolization Coils in 2032?
What was the global market size of Neurovascular Embolization Coils in 2026?
Which region is expected to have the highest market share?
Which companies rank high in the global Neurovascular Embolization Coils market?
Related Reports
Global Neurovascular Embolization Coils Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Neurovascular Embolization Coils market is projected to grow from US$ 1058 million in 2025 to US$ 1553 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-23
Pages: 172
USD 4900.00
(Single User License)
Global Neurovascular Embolization Coils Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Neurovascular Embolization Coils market size was US$ 1058 million in 2025 and is forecast to reach a readjusted size of US$ 1553 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032.
Published Date: 2026-08-23
Pages: 150
USD 4250.00
(Single User License)
Neurovascular Embolization Coils- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neurovascular Embolization Coils was estimated to be worth US$ 1058 million in 2025 and is projected to reach US$ 1553 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-08-23
Pages: 152
USD 3950.00
(Single User License)
Global Neurovascular Embolization Coils Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neurovascular Embolization Coils market size was US$ 118 million in 2024 and is forecast to a readjusted size of US$ 146 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
Global Neurovascular Embolization Coils Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neurovascular Embolization Coils market is projected to grow from US$ 118 million in 2024 to US$ 146 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 135
USD 4900.00
(Single User License)
Global Neurovascular Embolization Coils Market Research Report 2025
The global market for Neurovascular Embolization Coils was valued at US$ 118 million in the year 2024 and is projected to reach a revised size of US$ 146 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-01-16
Pages: 85
USD 2900.00
(Single User License)
Neurovascular Embolization Coils- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurovascular Embolization Coils was estimated to be worth US$ 118 million in 2024 and is forecast to a readjusted size of US$ 146 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 97
USD 3950.00
(Single User License)
Global Neurovascular Embolization Coils Market Insights, Forecast to 2030
Neurovascular Embolization Coils are used to treat a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.
Published Date: 2024-04-12
Pages: 113
USD 4900.00
(Single User License)
Global Neurovascular Embolization Coils Market Research Report 2024
Neurovascular Embolization Coils are used to treat a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.
Published Date: 2024-01-17
Pages: 93
USD 2900.00
(Single User License)
Neurovascular Embolization Coils - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Neurovascular Embolization Coils are used to treat a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.
Published Date: 2024-01-10
Pages: 123
USD 3950.00
(Single User License)
Global Neurovascular Embolization Coils Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Neurovascular Embolization Coils market is projected to grow from US$ 1058 million in 2025 to US$ 1553 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-23
Pages: 172
USD 4900.00 (Single User License)Global Neurovascular Embolization Coils Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Neurovascular Embolization Coils market size was US$ 1058 million in 2025 and is forecast to reach a readjusted size of US$ 1553 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032.
Published: 2026-08-23
Pages: 150
USD 4250.00 (Single User License)Neurovascular Embolization Coils- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neurovascular Embolization Coils was estimated to be worth US$ 1058 million in 2025 and is projected to reach US$ 1553 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-08-23
Pages: 152
USD 3950.00 (Single User License)Global Neurovascular Embolization Coils Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neurovascular Embolization Coils market size was US$ 118 million in 2024 and is forecast to a readjusted size of US$ 146 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
USD 4250.00 (Single User License)Global Neurovascular Embolization Coils Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neurovascular Embolization Coils market is projected to grow from US$ 118 million in 2024 to US$ 146 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 135
USD 4900.00 (Single User License)Global Neurovascular Embolization Coils Market Research Report 2025
The global market for Neurovascular Embolization Coils was valued at US$ 118 million in the year 2024 and is projected to reach a revised size of US$ 146 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-01-16
Pages: 85
USD 2900.00 (Single User License)Neurovascular Embolization Coils- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurovascular Embolization Coils was estimated to be worth US$ 118 million in 2024 and is forecast to a readjusted size of US$ 146 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 97
USD 3950.00 (Single User License)Global Neurovascular Embolization Coils Market Insights, Forecast to 2030
Neurovascular Embolization Coils are used to treat a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.
Published: 2024-04-12
Pages: 113
USD 4900.00 (Single User License)Global Neurovascular Embolization Coils Market Research Report 2024
Neurovascular Embolization Coils are used to treat a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.
Published: 2024-01-17
Pages: 93
USD 2900.00 (Single User License)Neurovascular Embolization Coils - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Neurovascular Embolization Coils are used to treat a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.
Published: 2024-01-10
Pages: 123
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
KEY FINDINGS
OVERVIEW
MARKET TRENDS
MARKET SEGMENTATION
MARKET DYNAMICS
INDUSTRY CHAIN ANALYSIS
SEGMENT INSIGHTS
DOWNSTREAM MARKET OPPORTUNITIES
REGIONAL INSIGHTS
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now